Latest Insights - page 4 | BiopharmaTrend

Latent Labs Launches AI Agent for Antibody Design From a Single Text Prompt

After emerging from stealth with a $50 million seed round last year, Latent Labs presents Latent-Y, an AI system that can generate antibody candidates directly from written research goals, reportedly …

Continue ›››

Earendil Labs Gets $787M to Push AI-Designed Antibodies Toward the Clinic

Earendil Labs has secured $787 million in financing to expand its AI-based biologics discovery and development platform, with backing from investors including Dimension Capital, DST Global Partners, Sanofi, and a …

Continue ›››

AI-Guided Brain Implant for Memory Loss Gets FDA Breakthrough Status

Boston-based Nia Therapeutics has received FDA Breakthrough Device Designation for its Smart Neurostimulation System (SNS), an implantable brain-computer interface (BCI) aimed at treating episodic memory loss in adults with prior …

Continue ›››

AlphaFold Database Now Includes Protein Pair Interactions

AlphaFold free access protein structure database, widely used for molecular biology research & reportedly containing almost every currently known protein, has been expanded to include predicted protein–protein interactions in the …

Continue ›››

Dyno Launches Open-Source Agentic Protein Design Suite at GTC 2026

During NVIDIA GTC 2026, Dyno Therapeutics introduced Psi-Phi, a suite of agentic AI models, filtering tools, and APIs designed to link computational protein design more directly with experimental results. The …

Continue ›››

Basecamp Launches Trillion Gene Atlas Targeting Over 100 Million Species for Better AI Training Data

Basecamp Research launched the Trillion Gene Atlas, a program designed to expand known genetic diversity by collecting genomic data from over 100 million species across thousands of global sites. The …

Continue ›››

$1 Billion-Backed Xaira Launches Its First Virtual Cell Model

Xaira Therapeutics has announced X-Cell, the company's first virtual cell model. It is a 4.9-billion-parameter diffusion language model designed to predict how cells respond to genetic perturbations, including in biological …

Continue ›››

Roche Launches its Own AI Factory for Drug Development

After purchasing 2,176 NVIDIA Blackwell GPUs, Roche announced the launch of a large-scale “AI factory” built on NVIDIA accelerated computing, aiming to integrate AI across drug discovery, development, and manufacturing.

Continue ›››

Arctoris Opens Biophysics Centre To Target Data Bottleneck in AI Drug Design

Arctoris, a UK-based partnership research organization (PRO), has launched the Biophysics Centre of Excellence, a major expansion of its laboratory footprint and instrumentation aimed at producing the experimental data that …

Continue ›››

Macrocyclic Peptide Startup Unnatural Products Raises $45M Series B After $3.5B in Pharma Deals

Santa Cruz-based biotech Unnatural Products, led by CEO and co-founder Cameron Pye, has secured $45 million in Series B financing led by The Venture Collective to expand its platform for …

Continue ›››

Simulating the Control Arm: Virtual Patients at the Trial Bottleneck

Digital twins promise smaller, faster trials, and the regulatory scaffolding is forming. But there’s still a validation gap. Clinical trials remain the most expensive bottleneck in drug development. And although …

Continue ›››

First Invasive BCI for Paralysis Cleared for Everyday Use in China

China’s National Medical Products Administration (NMPA) has authorized an implantable brain-computer interface (BCI) designed to help people with severe spinal cord injuries regain & augment basic hand movements for commercial …

Continue ›››